TA-270

• Description :

  TA-270, a novel quinolinone derivative, is a potent inhibitor of 5-lipoxygenase that plays an important role in asthma research[1].

• UNSPSC :

  12352005

• Target :

  Lipoxygenase

• Type :

  Reference compound

• Related Pathways :

  Metabolic Enzyme/Protease

• Field of Research :

  Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/ta-270.html

• Smiles :

  O=C(NC1=CC2=C(C=C1)C(O)=C(OCCCCCCCC)C(N2C)=O)/C=C/C3=CC(OC)=C(O)C(OC)=C3

• Molecular Formula :

  C29H36N2O7

• Molecular Weight :

  524.61

• References & Citations :

  [1]Y Aoki, et al. Inhibitory effect of a novel quinolinone derivative, TA-270, on asthmatic inflammatory responses in sensitized guinea pigs. Eur J Pharmacol. 2000 Dec 15;409 (3) :325-30.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  Phase 2

• CAS Number :

  [194037-25-7]